These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32708855)

  • 41. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel device for elimination of cancer cells from blood specimens.
    Weth A; Krol I; Priesner K; Donato C; Pirker S; Wolf C; Aceto N; Baumgartner W
    Sci Rep; 2020 Jun; 10(1):10181. PubMed ID: 32576883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetics of Circulating Tumor Cells in Breast Cancer.
    Bao-Caamano A; Rodriguez-Casanova A; Diaz-Lagares A
    Adv Exp Med Biol; 2020; 1220():117-134. PubMed ID: 32304083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signaling.
    Xin Y; Hu B; Li K; Hu G; Zhang C; Chen X; Tang K; Du P; Tan Y
    Cancer Lett; 2024 May; 590():216870. PubMed ID: 38614386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophils escort circulating tumour cells to enable cell cycle progression.
    Szczerba BM; Castro-Giner F; Vetter M; Krol I; Gkountela S; Landin J; Scheidmann MC; Donato C; Scherrer R; Singer J; Beisel C; Kurzeder C; Heinzelmann-Schwarz V; Rochlitz C; Weber WP; Beerenwinkel N; Aceto N
    Nature; 2019 Feb; 566(7745):553-557. PubMed ID: 30728496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic shear flow regulates biophysical characteristics and functions of circulating breast tumor cells reminiscent of brain metastasis.
    Jin J; Tang K; Xin Y; Zhang T; Tan Y
    Soft Matter; 2018 Dec; 14(47):9528-9533. PubMed ID: 30468439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EMT status of circulating breast cancer cells and impact of fluidic shear stress.
    Jin Y; Cai W; Zhao C; Yang F; Yang C; Zhang X; Zhou Q; Zhao W; Zhang C; Zhang F; Wang M; Li M
    Exp Cell Res; 2022 Dec; 421(1):113385. PubMed ID: 36228736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.
    Gradilone A; Naso G; Raimondi C; Cortesi E; Gandini O; Vincenzi B; Saltarelli R; Chiapparino E; Spremberg F; Cristofanilli M; Frati L; Aglianò AM; Gazzaniga P
    Ann Oncol; 2011 Jan; 22(1):86-92. PubMed ID: 20603432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
    Somlo G; Lau SK; Frankel P; Hsieh HB; Liu X; Yang L; Krivacic R; Bruce RH
    Breast Cancer Res Treat; 2011 Jul; 128(1):155-63. PubMed ID: 21499685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.
    Baccelli I; Schneeweiss A; Riethdorf S; Stenzinger A; Schillert A; Vogel V; Klein C; Saini M; Bäuerle T; Wallwiener M; Holland-Letz T; Höfner T; Sprick M; Scharpff M; Marmé F; Sinn HP; Pantel K; Weichert W; Trumpp A
    Nat Biotechnol; 2013 Jun; 31(6):539-44. PubMed ID: 23609047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
    Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Togo S; Shimizu H; Saito M
    J Transl Med; 2018 Oct; 16(1):287. PubMed ID: 30342534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.
    Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C
    Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical application of circulating tumor cells in breast cancer.
    Broersen LH; van Pelt GW; Tollenaar RA; Mesker WE
    Cell Oncol (Dordr); 2014 Feb; 37(1):9-15. PubMed ID: 24249155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
    Magbanua MJM; Rugo HS; Wolf DM; Hauranieh L; Roy R; Pendyala P; Sosa EV; Scott JH; Lee JS; Pitcher B; Hyslop T; Barry WT; Isakoff SJ; Dickler M; Van't Veer L; Park JW
    Clin Cancer Res; 2018 Mar; 24(6):1486-1499. PubMed ID: 29311117
    [No Abstract]   [Full Text] [Related]  

  • 59. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
    Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
    Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer.
    Savelieva OE; Tashireva LA; Kaigorodova EV; Buzenkova AV; Mukhamedzhanov RK; Grigoryeva ES; Zavyalova MV; Tarabanovskaya NA; Cherdyntseva NV; Perelmuter VM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.